Company / FCF Margin
4D Molecular Therapeutics, Inc. FCF Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-373975.7%
FY2025
5-year range
-373975.7% / -379.1%
FY2021-FY2025
Trend
-98545.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed -98546% YoY in FY2025, a notable deviation from the 5-year average annual change of -19812%.
Based on SEC 10-K filings.
-373975.7% in FY2025 with a 5-year CAGR of -373404.3%.
Declined from -3139.0% to -373975.7% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -373541.9pp
- 5-Year Change
- -373404.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin decreased 98545.7% year-over-year.
- Peak fcf margin was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -373975.7% | -98545.7% |
| FY2024 | -379.1% | +87.9% |
| FY2023 | -3139.0% | -623.7% |
| FY2022 | -433.8% | -13.7% |
| FY2021 | -381.3% | +33.3% |
| FY2020 | -571.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026